Upgrade to see committee overlap, performance context, and full expert analysis.
STZ congressional trades
7 matched disclosures
STZ congressional trades snapshot
This page summarizes public STOCK Act disclosures involving STZ. It is useful for seeing which lawmakers reported STZ transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Jan 12, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the STZ congressional trade page shows
Congressional Trader tracks 7 public STOCK Act disclosures for STZacross 4 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent STZ filing shown here was filed on Jan 12, 2026 by Gilbert Ray Cisneros as a purchase. Related lawmakers include Gilbert Ray Cisneros, Lisa C. McClain, Julie Johnson, Markwayne Mullin.
Top lawmakers for STZ
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded STZ?
Recent STZ disclosures include Gilbert Ray Cisneros, Lisa C. McClain, Julie Johnson, Markwayne Mullin.
What is the buy/sell mix for STZ?
The visible sample currently shows 4 purchases and 3 sales or partial sales.
Should I trade based on STZ disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.